Cervical Screening Awareness Week is an annual event which will run from 15th to 21st June 2020. Cervical cancer is the most common form of cancer in women under 35 with two women in the UK per day dying from the disease. Regular cervical screening appointments can prevent up to 75% of instances of cervical cancer, saving 5000 lives per year. Despite this, many women are reluctant to have this test done with a quarter of women not responding to their screening invitation. Cervical Screening Awareness Week is organised by the charity Jo’s trust, a charity dedicated to women affected by cervical cancer or abnormalities.Advertisements

Cervical Screening Awareness week aims to encourage all women to have regular cervical screening as well as to provide information and reassurance around any fears or embarrassment that women may have concerning taking the test.

During the week there will be information stands at GP surgeries, workplaces and sports centres, fundraising events and a social media campaign where women are urged to tell their stories relating to cervical cancer and cervical screening.

More information about Cervical Screening Awareness Week and information about cervical cancer and cervical screening itself can be found on the Jo’s Trust website http://www.jostrust.org.uk or from your local GP’s office.

https://www.awarenessdays.com/awareness-days-calendar/cervical-screening-awareness-week-2021/

Like many young people, my cancer diagnosis didn’t come very quickly. It wasn’t easy convincing anyone I wasn’t well.

It all started with an uncomfortable pain in my side. It wouldn’t go away so I visited my GP, and after some pestering, I was sent for a scan to look for possible endometriosis. The scan actually showed a 7cm cyst in my left ovary. The doctor told me it would have to be removed through key-hole surgery, but I would be on a waiting list as it wasn’t urgent.

I wasn’t happy with this at all. For the eight months I waited for that operation I was bothering every doctor I could find, telling them that I just felt wrong. Nobody would listen, but I knew something strange was happening because I was constantly tired. I quit everything I loved, I’m a singer and musical theatre performer but I stopped performing completely.

I remembered the cancer awareness session we’d had in school a few years ago from Teenage Cancer Trust really vividly, and I remembered them telling us to be persistent if we felt something wasn’t right. I listened to this, and I might not be here today without that advice.

When the time came to remove the cyst, I told the surgeon I had concerns, and for the first time someone listened to me. In hindsight, this conversation may have saved my life. The surgeon agreed to have an extra look about while he was in there. When I woke up from my operation the surgeon had removed the cyst but had also found something else. He thought it was scar tissue and sent it for testing. He told me it was most likely an infection.

A few weeks later he called my parents on a Friday. I wasn’t in but he told them to come with me for an urgent scan on Monday. I said to my parents “I think I have cancer” but they thought I was being dramatic. I just knew it. On the Monday, I had the scan and met with the surgeon. He said he had the results from the tissue he’d sent away.

He said: “Its cancer.” I don’t remember the rest of the meeting. I couldn’t speak. I felt numb. How could this be happening to me? I was 19 and scared. I felt alone.

Read more: https://www.teenagecancertrust.org/get-help/young-peoples-stories/amy-glasgow

Why No One Is Talking About Ovarian Cancer?
Even during Ovarian Cancer Awareness Month in September, it felt like women were keeping quiet about the disease. Why is it so hush-hush?

Every October, we start seeing pink. Pink ribbons on t-shirts. Pink armbands on football players. Pink-themed walks, 5Ks, and marathons—all efforts aimed to support Breast Cancer Awareness Month, which was started in 1985 to encourage women to get their yearly mammograms. Since then, the month has blown up into an anticipated, annual phenomenon.

But lost in that shuffle is September’s Ovarian Cancer Awareness Month, represented by the color teal. Although the disease is rare compared to breast cancer, the statistics are far more grim. And few people are talking about them.

According to the National Cancer Institute, roughly 21,290 new cases of ovarian cancer will be diagnosed in 2015—yet 14,180 women will also die. The five-year survival rate for the disease is just 45.6 percent, compared to breast cancer’s roughly 90 percent. Often, since early-stage symptoms of the cancer are very mild, we don’t catch ovarian cancer until it’s too late. In 61 percent of cases diagnosed, the cancer has metastasized, which reduces five-year survival rates to just 27.4 percent. (Learn the facts! 4 Things You Didn’t Know About Ovarian Cancer.)

Why Ovarian Cancer Is Less Talked About
If ovarian cancer is the deadlist gynecologic cancer, why aren’t we seeing more of that blue-green spattered everywhere? There are several reasons, according to Nimesh Nagarsheth, M.D., an associate professor of Obstetrics, Gynecology, and Reproductive Science at Icahn School of Medicine at Mount Sinai, who helps raise funds and awareness for gynecologic cancers with a rock band of six gynecologic oncologists called N.E.D.

1. Ovarian cancer isn’t as prevalent as breast cancer. There hasn’t been a real high-profile public figure diagnosed with ovarian cancer in some time (not since SNL alum Gilda Radner in the 1980s), who might carry the torch for the disease. With new cases of breast cancer hitting the news all the time—from Rita Wilson to Elizabeth Edwards, Robin Roberts to Giuliana Rancic—it’s on the public’s mind more often.

2. Docs are more focused on work than awareness. While we’re all thankful to be talking openly about breast cancer, and the success of October’s pink ribbon is amazing and unparalleled, we’re still trying to hit our stride with ovarian awareness, says Nargarsheth. “In terms of gynecologic cancers, as a field, we’ve probably been a little more focused on the work as opposed to the awareness aspect.” For instance, doctors have been working on identifying the key emerging symptoms of ovarian cancer—like bloating, early satiety while eating, urinary frequency or urgency, pelvic or abdominal pain, so women can get diagnosed earlier and survive the disease. (You can lend your support to the disease by participating in these 6 Ways to Help Fight Ovarian Cancer.)

3. Some women mistakenly think they’re covered. “For breast cancer, we have the mammogram and even the self-exam,” says Lindsay Avner, the founder of Bright Pink, an organization aimed at educating women on their breast and ovarian health. “These are external organs that you can check; you can feel lumps. For cervical cancer, we have pap smears given by your ob-gyn—but these don’t screen for ovarian cancer, which many women don’t realize.” (More on what your options for an ovarian cancer screening are later.)

With annual pap smears and all the ads for Gardasil taking over the airwaves, many young women believe they’re protected for all gynecologic cancers, she adds. “The pap smear gets a lot of play, and we’ve sort of fallen prey to the marketing,” says Avner.

4. Some think ovarian cancer is an automatic death sentence (it’s not). “While breast cancer is the most common form of cancer in women, ovarian cancer is the deadliest,” says Avner. “So we do not have that army of survivors like we do with breast cancer, helping to raise awareness.” But the perception of deadliness is another reason we’re not hearing enough about ovarian cancer. The thing is, if diagnosed in the early stages, survival rates jump to more than 90 percent in stage one, and more than 70 percent for stage two. “We want to get beyond the ‘this is so deadly, this is so sad’ conversation” Avner says. “We really want women to know the symptoms and advocate for themselves.”

Here’s how to do just that:

The Symptoms
Subtle as they are, it’s important to be aware of symptoms, says Nargasheth. “Symptoms that may appear at an early stage can often seem vague and musculoskeletal,” he explains. “This might be bloating, pelvic or abdominal pain, getting full quickly while eating, appetite changes, weight loss or gain, and pressure on the bladder. A lot of women complain that they have trouble wearing pants, or that they can’t button their pants.” If you’re experiencing any of these for a week or more and they feel abnormal for your body, trust your gut and get checked. “It’s easy to pass off,” Avner says. “We all feel bloating, we eat too much Chinese food—whatever the case. But if a symptom persists, you have to see your doctor. Say what’s on your mind. Ask, ‘Could this be my ovaries?'”

Can You Protect Yourself?
Research has shown that some factors lower your risk of ovarian cancer, like taking birth control for more than two years, having children, and breastfeeding. “We’re realizing the progesterone component is probably the key to prevention,” Nargarsheth says. Progesterone—a hormone produced in the ovaries that peaks during pregnancy and while on some forms of birth control—helps maintain the health of your uterus, regulates your monthly cycle, and assists in bringing pregnancies to term. And science is starting to show that progesterone may even destroy cancer cells. In addition, reducing ovulation while taking birth control, breastfeeding, or being pregnant may help lower your risk. (And a recent study found that drinking this Tea Could Protect Against Ovarian Cancer.)

Is There Screening?
The best potential screening test available right now is the CA-125, which measures the levels of a protein that may be elevated in around 80 percent of ovarian cancer cases. If you’re high-risk (you can quickly check with Bright Pink’s Assess Your Risk tool), you can ask your doctor about getting this test; the younger you get the test, the easier it will be to figure out what your normal levels are. That said, Avner reminds that not every person with ovarian cancer will have an elevated CA-125—including her mother, whose CA-125 results were perfectly normal when she was diagnosed.

“As of now, there is no effective test that we’re advocating for everyone,” Nagarsheth explains. “Sometimes, screening tests can do more harm than good, causing a lot of anxiety over false positives, or even getting false negatives.” Talk to your doc if you have questions.

If you have a strong family history of breast or ovarian cancer, you also might want to get tested for the BRCA-1 and BRCA-2 genes. The average woman has a 1.3 percent chance of developing ovarian cancer in her lifetime—but that jumps to 39 percent and 11 to 17 percent respectively, if you carry either of the two gene mutations. If you carry these genes, preventative surgeries to remove the Fallopian tubes or ovaries—like Angelina Jolie had earlier this year—are options.

Culled- Shape

http://www.shape.com/lifestyle/mind-and-body/why-no-one-talking-about-ovarian-cancer

Ten out of 32 women who wanted to become pregnant and had transplant succeeded in having a baby, and none had cancer recurrence as a result. Ovarian tissue transplants for women who want to have a baby after cancer treatment appear to be safe and are very successful, according to a team of experts in Denmark, where the procedure is routinely offered.

One in three young women who had a transplant and wanted to become pregnant succeeded in having a baby, analysis of results over the last 10 years has shown. Half of the children were conceived naturally, without the help of IVF.

The study, published in the journal Human Reproduction, is likely to be a game-changer. Many doctors have been wary of ovarian tissue transplants, worried that they might cause a return of the cancer. But among the 41 women in the study, none had a recurrence as a result.

The successes also bring closer the potential option for women to postpone having a family by having ovarian tissue frozen until they are established in a relationship or career, without having to worry about the ticking of the reproductive clock.

In Denmark, young women with cancer are routinely offered ovarian tissue freezing, but it is not automatic in the UK or elsewhere.

“We are saying for the first time we have a cohort of patients who definitely seem to benefit from this and none of those women have had a cancer as a result of transplanting the tissue,” said one of the study’s authors, Prof Claus Yding Andersen, of the Laboratory of Reproductive Biology in the Rigshospitalet, Copenhagen.

“Most surprising to me is that we have patients who have tissue that is active more than 10 years after the transplant.” Some of the women asked for the transplant because they hoped to start a family, but others did it to reverse the early menopause their treatment had triggered. “We have women who say ‘I don’t have a partner at the moment but I don’t want this menopause’,” said Andersen.

“Of course, if you have a cancer as a young woman, all of them say ‘I would like to survive’, but immediately after that most of them say ‘is it possible to preserve my fertility’. It is a huge issue for the patients.”

If the procedure can be shown to be safe and effective, it opens the way to young women having ovarian tissue removed and frozen so that they can postpone having children until the time seems right for them, whether because they have established themselves in a career or found the right partner.

“This is a theoretical adaptation,” said Andersen. “I think it is a bit early to take it that far but in a few years, when we know even better what we are doing, it may become an option.”

Denmark leads the world in ovarian transplantation. “I’m always asked how can it be that a small country with five million people is having the largest experience with this worldwide,” said Andersen. “Here we have a public healthcare system and women are offered the procedure for free. We take out the ovary and cryopreserve it for free and transplant it for free.

“Colleagues in the UK have been sceptical about the safety and longevity of the tissue. They were asking are you sure you are doing no harm? But there are lots of clinics in London starting to offer it now.”

At least 36 babies have been born following the procedure, mostly in Denmark. Germany, Spain, Israel and Belgium have also done significant numbers of transplants. “The results are very encouraging for a continued effort,” Andersen said.

The study is a review of the largest series of ovarian transplants performed worldwide. The experts looked at the outcomes for 41 women, who had 53 transplants of thawed ovarian tissue between them over a period of 10 years. Among the women, 32 wanted to become pregnant and 10 succeeded in having babies – a total of 14 children in all. Some others became pregnant but there was one miscarriage and two abortions, one because a relationship broke down and the other because the woman’s cancer returned, unconnected with the transplant.

The Danish procedure involves removal and cryopreservation of one ovary. During transplantation, part of that ovary is cut into 25 small pieces and inserted into the remaining ovary, which then regains its function. The hormonal cycle resumes and an egg is produced each month. Half the children born were conceived naturally. The tissue can be transplanted elsewhere in the abdominal cavity if necessary, which means IVF will be required.

Grete Brauten-Smith, clinical nurse specialist at Breast Cancer Care, said young women facing cancer treatment must be offered advice on their options from a fertility specialist.

“Chemotherapy treatment can cause infertility – a massive worry for thousands of younger women with breast cancer. So it is very encouraging to see these improving success rates for freezing ovarian tissue,” she said. “This could, in future, offer another valuable option for those who face the devastating prospect of not being able to start or add to their family.

“It is vital women are offered a referral to a fertility expert before starting treatment. Only then will they be able to make an empowered decision about their future fertility.”

Sarah Boseley, Health editor

The Guardian http://www.theguardian.com/society/2015/oct/07/ovarian-tissue-transplants-safe-successful-study

Those women who put their fertility “on ice” because of cancer also have little risk of the disease coming back as a result of the transplanted tissue.

The research, published in the journal Human Reproduction, found that transplanted ovarian tissue can last at least 10 years in some cases, giving women several chances to bear children.

The successful treatment could pave the way for fertility to be restored in many more women who, until now, have been unable to have babies due to the harsh effects of some medical treatments.

In the latest analysis, experts reviewed 41 Danish women who had a total of 53 transplants of thawed ovarian tissue, and who were followed for a decade.

The average age when tissue was frozen was 29.8 years. Out of the 41 women, 32 wished to become pregnant. Ten (31 per cent) were successful and had at least one child.

Overall, 14 children were born to the 41 women – eight naturally and six through IVF.

There were also two abortions during the study – one because the woman was separating from her partner and the other because of recurrent breast cancer.

A third woman experienced a miscarriage at 19 weeks.

Dr Annette Jensen, from the Rigshospitalet, Copenhagen, Denmark, who worked on the study, said preserving fertility has increasingly become part of the treatment plan for young cancer patients.

Overall, almost 800 women have had ovarian tissue frozen as part of a programme started in Denmark in 2000.

Dr Jensen said: “As far as we know, this is the largest series of ovarian tissue transplantation performed worldwide, and these findings show that grafted ovarian tissue is effective in restoring ovarian function in a safe manner.

“The fact that cancer survivors are now able to have a child of their own is an immense quality-of-life boost tor them.”

Three of the 41 women in the study had their cancer return. Two of them had breast cancer at the site of their original tumours, while a Ewing’s sarcoma patient suffered a relapse.

The researchers said none of the recurrences appeared to be related to the transplants.

Dr Jensen said: “It’s important that women who have received transplanted ovarian tissue continue to be followed up.

“In particular, we have not performed transplants in patients who have suffered from leukaemia, since the ovarian tissue may harbour malignant cells in this group of patients.”

Dr Jensen said she hoped the study would “enable this procedure to be regarded as an established method in other parts of the world”.

http://www.stuff.co.nz/life-style/parenting/pregnancy/conception/72836237/New-study-gives-baby-hope-to-women-with-ovarian-cancer